{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:59:22Z","timestamp":1794607162117,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272829"],"award-info":[{"award-number":["82272829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172736"],"award-info":[{"award-number":["82172736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1459700"],"award-info":[{"award-number":["22ZR1459700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biomaterials.2024.122609","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T08:27:35Z","timestamp":1715156855000},"page":"122609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism"],"prefix":"10.1016","volume":"309","author":[{"given":"Yi","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0350-4760","authenticated-orcid":false,"given":"Xianwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9593-176X","authenticated-orcid":false,"given":"Jiangtao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-1477","authenticated-orcid":false,"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-7845","authenticated-orcid":false,"given":"Yourong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biomaterials.2024.122609_bib1","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122609_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2022.11.005","article-title":"Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma","volume":"78","author":"Merters","year":"2023","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122609_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2468-1253(21)00196-5","article-title":"Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study","volume":"6","author":"Javle","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/1078-0432.CCR-23-1317","article-title":"Landscape of clinical resistance mechanisms to FGFR inhibitors in FGFR2-altered cholangiocarcinoma","volume":"30","author":"Wu","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122609_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trecan.2020.10.004","article-title":"Fat and Furious: lipid metabolism in antitumoral therapy response and resistance","volume":"7","author":"Bacci","year":"2021","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib6","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","article-title":"Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122609_bib7","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/01.ATV.0000140818.00570.2d","article-title":"Hepatic lipase, lipoprotein metabolism, and atherogenesis","volume":"24","author":"Santamarina-Fojo","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122609_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122609_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2022.10.028","article-title":"Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice","volume":"78","author":"Chen","year":"2023","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122609_bib10","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1194\/jlr.R200008-JLR200","article-title":"Hepatic lipase","volume":"43","author":"Jansen","year":"2002","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122609_bib11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1021\/acsmedchemlett.8b00424","article-title":"Sulfonylated benzothiazoles as inhibitors of endothelial lipase","volume":"9","author":"Johnson","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","article-title":"FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth","volume":"8","author":"Wei","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122609_bib13","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.7150\/thno.44868","article-title":"FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib14","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/s41467-020-18565-8","article-title":"CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis","volume":"11","author":"Hao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2024.122609_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122333","article-title":"An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway","volume":"302","author":"Feng","year":"2023","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122609_bib16","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1021\/acsnano.2c06587","article-title":"Mechanistic principles for engineering hierarchical porous metal-organic frameworks","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.biomaterials.2024.122609_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100333","article-title":"Conferring Ti-based MOFs with defects for enhanced sonodynamic cancer therapy","volume":"33","author":"Liang","year":"2021","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.biomaterials.2024.122609_bib18","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1039\/D1CS00403D","article-title":"Advanced biotechnology-assisted precise sonodynamic therapy","volume":"50","author":"Zhang","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2024.122609_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122252","article-title":"Ultrasound-activated nanosonosensitizer for oxygen\/sulfate dual-radical nanotherapy","volume":"301","author":"Qiao","year":"2023","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122609_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stem.2021.02.011","article-title":"Mitochondria as signaling organelles control mammalian stem cell fate","volume":"28","author":"Chakrabarty","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122609_bib21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s42255-019-0126-8","article-title":"Voltage-energized calcium-sensitive ATP production by mitochondria","volume":"1","author":"Wescott","year":"2019","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","article-title":"Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122609_bib23","article-title":"Overcome drug resistance in cholangiocarcinoma: new insight into mechanisms and refining the preclinical experiment models","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122609_bib24","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1021\/acsnano.2c05262","article-title":"Role of inorganic amorphous constituents in highly mineralized biomaterials and their imitations","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122609_bib25","doi-asserted-by":"crossref","first-page":"16932","DOI":"10.1021\/acsnano.2c06996","article-title":"Synergistically activated Pd atom in polymer-stabilized Au23Pd1 cluster","volume":"16","author":"Hasegawa","year":"2022","journal-title":"ACS Nano"},{"issue":"45","key":"10.1016\/j.biomaterials.2024.122609_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102271","article-title":"Calcium phosphate-reinforced metal-organic frameworks regulate adenosine-mediated immunosuppression","volume":"33","author":"Liang","year":"2021","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122609_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4161\/cc.23517","article-title":"Prognostic value of LIPC in non-small cell lung carcinoma","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122609_bib28","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00432-022-03957-8","article-title":"CD36: an emerging therapeutic target for cancer and its molecular mechanisms","volume":"148","author":"Ruan","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122609_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1535-7163.MCT-11-0289","article-title":"Identification of docetaxel resistance genes in castration-resistant prostate cancer","volume":"11","author":"Mar\u00edn-Aguilera","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122609_bib30","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1039\/c3nr05559k","article-title":"Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells","volume":"6","author":"Pozzi","year":"2014","journal-title":"Nanoscale"},{"issue":"43","key":"10.1016\/j.biomaterials.2024.122609_bib31","article-title":"Mito-bomb: targeting mitochondria for cancer therapy","volume":"33","author":"Guo","year":"2021","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122609_bib32","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122609_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.027","article-title":"Mitocytosis, a migrasome-mediated mitochondrial quality-control process","volume":"184","author":"Jiao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2024.122609_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121163","article-title":"Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma","volume":"278","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122609_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122609_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbadis.2018.03.026","article-title":"Animal models of cholangiocarcinoma","volume":"1865","author":"Loeuillard","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122609_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.gastro.2021.10.015","article-title":"MicroRNA-15a\/16-1 prevents hepatocellular carcinoma by disrupting the communication between kupffer cells and regulatory T cells","volume":"162","author":"Liu","year":"2022","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122609_bib38","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice","volume":"122","author":"Fan","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"29","key":"10.1016\/j.biomaterials.2024.122609_bib39","doi-asserted-by":"crossref","first-page":"12117","DOI":"10.1073\/pnas.0702955104","article-title":"Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer","volume":"104","author":"Rottenberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122609_bib40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11596-019-2125-0","article-title":"Notch1 drives the formation and proliferation of intrahepatic cholangiocarcinoma","volume":"39","author":"Guo","year":"2019","journal-title":"Curr Med Sci"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122609_bib41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41419-020-2509-x","article-title":"Oncogenic driver genes and tumor microenvironment determine the type of liver cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122609_bib42","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.32483","article-title":"Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib43","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.biomaterials.2024.122609_bib44","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.3390\/cells11223556","article-title":"CD36-Fatty acid-mediated metastasis via the bidirectional interactions of cancer cells and macrophages","volume":"11","author":"Zaidi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2024.122609_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122609_bib46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jhep.2017.07.006","article-title":"Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice","volume":"67","author":"Zhang","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metabol."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122609_bib48","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: from threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122609_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/lifemeta\/loac038","article-title":"Lipid metabolism in tumor-infiltrating T cells: mechanisms and applications","volume":"1","author":"Ke","year":"2022","journal-title":"Life Metab"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122609_bib50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"14","key":"10.1016\/j.biomaterials.2024.122609_bib51","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","article-title":"Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor","volume":"74","author":"Mittal","year":"2014","journal-title":"Cancer Res."},{"issue":"7531","key":"10.1016\/j.biomaterials.2024.122609_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature13816","article-title":"Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors","volume":"516","author":"Gnad","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122609_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.1683","article-title":"Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia","volume":"10","author":"Rosenberger","year":"2009","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40824-022-00262-w","article-title":"Sequential activation of M1 and M2 phenotypes in macrophages by Mg degradation from Ti-Mg alloy for enhanced osteogenesis","volume":"26","author":"Liang","year":"2022","journal-title":"Biomater. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16214-2","article-title":"Titania nanospikes activate macrophage phagocytosis by ligand-independent contact stimulation","volume":"12","author":"Kartikasari","year":"2022","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122609_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209435120","article-title":"The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation","volume":"120","author":"Ma","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.biomaterials.2024.122609_bib58","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.3390\/ijms20143383","article-title":"Inhibition of phosphatidylinositol 3-kinase (PI3K) signaling synergistically potentiates antitumor efficacy of paclitaxel and overcomes paclitaxel-mediated resistance in cervical cancer","volume":"20","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2024.122609_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.12659\/MSM.912929","article-title":"Everolimus reverses palbociclib resistance in ER+ human breast cancer cells by inhibiting phosphatidylinositol 3-kinase(PI3K)\/Akt\/Mammalian target of rapamycin (mTOR) pathway","volume":"25","author":"Chen","year":"2019","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35807-4","article-title":"Cross-platform comparison of untargeted and targeted lipidomics approaches on aging mouse plasma","volume":"8","author":"Contrepois","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib61","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122609_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122609_bib63","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122609_bib64","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0022-2275(20)39746-7","article-title":"Cholesterol uptake by the 'selective' pathway of ovarian granulosa cells: early intracellular events","volume":"36","author":"Reaven","year":"1995","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122609_bib65","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2024.122609_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-7592-1_4","article-title":"Lipid mediator metabolomics via LC-MS\/MS profiling and analysis","volume":"1730","author":"Dalli","year":"2018","journal-title":"Methods Mol. Biol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:07:25Z","timestamp":1777486045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":66,"alternative-id":["S0142961224001431"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122609","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122609"}}